We are live on ! Find out more
DICE

DICE Therapeutics, Inc. Common Stock
DICE

Delisted

DICE was delisted on the 8th of August, 2023.

Back to rankings

69 hedge funds and large institutions have $799M invested in DICE Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 9

77% more funds holding

Funds holding: 39 → 69 (+30)

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

1% more capital invested

Capital invested by funds: $794M → $799M (+$5.71M)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

Holders
69
Holders Change
+30
Holders Change %
+76.92%
% of All Funds
1.06%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
40
Increased
9
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$25.1M
2
PA
Perceptive Advisors
New York
+$20.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$17.1M
4
LGM
Logos Global Management
California
+$14.8M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$7.34M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.8M
2
O
OrbiMed
New York
-$14.4M
3
Millennium Management
Millennium Management
New York
-$8.91M
4
ACA
Avoro Capital Advisors
New York
-$6.96M
5
SFM
Sphera Funds Management
Israel
-$2.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$4.75M +$5.49M +187,494 New
ACM
27
Asymmetry Capital Management
California
$4.69M -$2.64M -89,964 -33%
MIM
28
Miller Investment Management
Pennsylvania
$4.58M – – –
Northern Trust
29
Northern Trust
Illinois
$3.16M +$3.66M +124,768 New
Citadel Advisors
30
Citadel Advisors
Florida
$2.77M +$3.2M +109,356 New
Bank of America
31
Bank of America
North Carolina
$2.48M +$2.83M +96,650 +8,205%
Charles Schwab
32
Charles Schwab
California
$2.33M +$2.7M +92,144 New
PAMP
33
Polar Asset Management Partners
Ontario, Canada
$1.9M +$2.2M +75,014 New
HM
34
HealthCor Management
New York
$1.89M +$937K +31,974 +75%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$1.62M +$1.88M +64,146 New
Millennium Management
36
Millennium Management
New York
$1.58M -$8.91M -304,063 -83%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$1.2M +$193K +6,600 +16%
Marshall Wace
38
Marshall Wace
United Kingdom
$1.07M – – –
AI
39
Atom Investors
Texas
$990K +$1.15M +39,100 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$844K +$977K +33,343 New
Morgan Stanley
41
Morgan Stanley
New York
$823K +$953K +32,531 New
PPA
42
Parametric Portfolio Associates
Washington
$695K +$805K +27,472 New
N
43
Nuveen
North Carolina
$533K +$617K +21,064 New
NFGH
44
Nan Fung Group Holdings
Hong Kong
$499K +$577K +19,700 New
JF
45
Jump Financial
Illinois
$393K +$454K +15,500 New
LP
46
LMR Partners
United Kingdom
$389K -$1.31M -44,613 -74%
CSS
47
Cubist Systematic Strategies
Connecticut
$361K +$418K +14,270 New
Citigroup
48
Citigroup
New York
$353K +$370K +12,626 +967%
Tudor Investment Corp
49
Tudor Investment Corp
Connecticut
$313K -$2.1M -71,601 -85%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$262K +$303K +10,332 New
1
2
3 4

DICE Hedge Fund Activity: Q4 2021 in Review

69 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in DICE Therapeutics, Inc. Common Stock (DICE) for Q4 2021, worth a combined $799M — up 0.72% from $794M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new DICE positions and 9 closed out — a net gain of 31 holders — while 9 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $25.1M. The largest seller was Fidelity Investments, cutting an estimated $16.8M.

  • 69 institutional investors held DICE Therapeutics, Inc. Common Stock (DICE) as of Q4 2021, up from 39 in Q3 2021.
  • Funds reported $799M of DICE Therapeutics, Inc. Common Stock stock for Q4 2021, up 0.72% quarter-over-quarter.
  • 40 funds opened new DICE Therapeutics, Inc. Common Stock positions in Q4 2021 and 9 closed out, a net change of +31 holders.
  • The largest DICE Therapeutics, Inc. Common Stock buyer in Q4 2021 was BlackRock, an estimated $25.1M added.
  • The largest DICE Therapeutics, Inc. Common Stock seller in Q4 2021 was Fidelity Investments, an estimated $16.8M sold.

Based on aggregated 13F filings for Q4 2021.